FibroGen (FGEN) Tops Q1 EPS by 15c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of $0.05, $0.15 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.74 million versus the consensus estimate of $35.5 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Santacruz Silver reports employee fatality at Bolivia's Reserva mine
• FTI Consulting names Dean Felton as Senior Managing Director in Australia